TAK-672

· Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-672, covering 2024-12-02 to 2024-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of TAK-672 in Participants With Acquired Hemophilia A [Phase 2, Phase 3]